RM vs TMO · P/E 7.5, rev $588.5M vs P/E 24, rev $44.56B
Regional Management Corp (RM) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Regional Management Corp (RM) is a credit services company listed on NYSE.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported RM revenue for 2024-12-31 was $588.5M. Net income was $41.2M. Revenue was up 6.7% from 2023-12-31 to 2024-12-31. RM currently screens at market cap $339.8M and trailing P/E 7.5.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
RM currently screens at market cap $339.8M and trailing P/E 7.5. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the RM and TMO stock pages for the full models.
Not investment advice.